DIAGNOSIS AND TREATMENT OF RARE GYNECOLOGIC CANCERS

DIAGNOSIS AND TREATMENT OF RARE GYNECOLOGIC CANCERS

Editorial:
ELSEVIER UK
Año de edición:
Materia
Ginecología
ISBN:
978-0-323-82938-0
Páginas:
384
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 10 días

Descuento:

-5%

Antes:

97,00 €

Despues:

92,15 €

• Section 1 - Ovarian Cancer
1. Malignant Germ Cell Tumors
2. Sex Cord-Stromal Tumors
3. Malignant Mixed Mesodermal Tumor
4. Clear Cell Carcinoma
5. Mucinous Carcinomas
6. Low-Grade Serous Tumors (MPSC) and Variants
7. Small Cell (hypercalcemic)
8. Other rare ovarian cancers (Small Cell Carcinoma (hypercalcemic), Small Cell Carcinoma (Neuroendocrine, Mesolthelioma, Squamous Cell, Sarcomas)
• Section 2 – Uterine Cancer
9. Leiomyosarcoma
10. Other sarcomas of the uterus (Endometrial Stromal Sarcoma, STUMP, adenosarcoma)
11. Carcinosarcoma
12. Uterine Serous Carcinoma
13. Other rare uterine cancers (Choriocarcinoma, Yolk Sac, Neuroendocrine)
• Section 3 – Cervical Cancer
14. High Grade Neuroendocrine Carcinoma
15. Other rare cervical cancers (Verrucous Carcinoma, Clear Cell Carcinoma, Adenoid Cystic Carcinoma, Rhabdomyosarcoma)
• Section 4 – Vulvovaginal Cancers
16. Clear Cell Carcinoma
17. Melanoma
18. Bartholin Gland Carcinoma
19. Benign and Malignant Paget’s Disease
20. Other rare vulvovaginal carcinomas (Verrucous Carcinoma, Embryonal Rhabdomyosarcoma, Yolk Sac Tumor, Aggressive Angiomyxoma, Sarcomas
• Section 5 – Trophoblastic Disease
21. Gestational Trophoblastic Disease and Placental Site Trophoblastic Tumor

Offering a one-stop guide to recognition and therapeutic decision making, Diagnosis and Treatment of Rare Gynecologic Cancers fills a gap in the medical literature on uncommon ovarian, uterine, cervical, and vulvovaginal cancers and trophoblastic diseases. This authoritative text, edited by Drs. Michael Frumovitz, Mario Leitao, and Preetha Ramalingam, has been authored by internationally recognized experts from top institutions such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Each chapter covers different cancer subtypes and has been reviewed by an oncologist and a pathologist.

Authors
• Michael Frumovitz, MD, PhD , Professor, Gynecologic Oncology, MD Anderson Cancer Center.
• Mario M. Leitao Jr., MD, Member and Fellowship Director, Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medical College.
• Preetha Ramalingam, Professor, Anatomic Pathology, MD Anderson Cancer Center